THORNBURG INVESTMENT MANAGEMENT INC
Position in BMY — Bristol Myers Squibb Co
CIK 1145020
SANTA FE, NM
Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,212,608
-$116,352 QoQ
Shares Held
38,400
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#792
of 2,514 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THORNBURG INVESTMENT MANAGEMENT INC holds $1,317,069,132 across 7 Drug Manufacturers - General names. BMY ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,891,426 | $548,272,198 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,787,976 | $486,754,916 | |
| 3 | ABBV |
AbbVie Inc.
|
541,146 | $136,173,979 | |
| 4 | LLY |
ELI LILLY & Co
|
79,682 | $95,572,989 | |
| 5 | PFE |
Pfizer Inc
|
1,970,004 | $47,437,696 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
38,400 | $2,212,608 | |
| 7 | NVS |
Novartis AG
|
4,114 | $644,746 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,212,608 | 38,400 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,328,960 | 38,400 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,071,296 | 38,400 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,731,840 | 38,400 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,777,536 | 38,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,342,016 | 38,400 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,171,904 | 38,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,579,890 | 69,190 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,873,460 | 69,190 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||